STOCK TITAN

[Form 4] MEI Pharma, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Flynn James P, a director of Lite Strategy, Inc. (ticker LITS), reported a purchase of 10,000 shares of the company's common stock on 09/30/2025. The filing shows a weighted-average purchase price of $2.543 per share, with individual transactions priced between $2.51 and $2.58. After the acquisition, Flynn beneficially owned 17,900 shares.

The Form 4 was submitted on 10/02/2025 and signed by an attorney-in-fact. The reporting person offers to provide details on the split of share counts by price within the disclosed range upon request.

Flynn James P, un direttore di Lite Strategy, Inc. (ticker LITS), ha riferito l'acquisto di 10,000 azioni ordinarie della società in data 09/30/2025. Il deposito mostra un prezzo medio ponderato di acquisto di $2.543 per azione, con transazioni individuali valutate tra $2.51 e $2.58. Dopo l'acquisizione, Flynn deteneva beneficiamente 17,900 azioni.

La presentazione del Form 4 è stata inviata il 10/02/2025 e firmata da un procuratore-in-fatto. La persona che segnala si offre di fornire dettagli sulla ripartizione del numero di azioni per prezzo all'interno dell'intervallo divulgato su richiesta.

Flynn James P, un director de Lite Strategy, Inc. (símbolo LITS), informó la compra de 10,000 acciones de las acciones ordinarias de la empresa el 09/30/2025. El informe muestra un precio de compra medio ponderado de $2.543 por acción, con transacciones individuales valuadas entre $2.51 y $2.58. Después de la adquisición, Flynn poseía beneficiosamente 17,900 acciones.

El Form 4 fue presentado el 10/02/2025 y firmado por un apoderado. La persona reportante ofrece proporcionar detalles sobre la distribución del conteo de acciones por precio dentro del rango divulgado a solicitud.

Flynn James P는 Lite Strategy, Inc.의 이사이며(주식 코드 LITS), 09/30/2025에 회사의 보통주 10,000주를 매수했다고 보고했다. 제출 서류에는 주당 가중평균 매수 가격이 $2.543이며, 개별 거래는 $2.51에서 $2.58 사이로 책정되었다. 인수 후 Flynn은 유익하게 17,900주를 소유하게 되었다.

Form 4는 10/02/2025에 제출되었고 대리인에 의해 서명되었다. 보고자는 공개된 범위 내의 가격별 주식 수 분할에 대한 세부 정보를 요청 시 제공하겠다고 제안한다.

Flynn James P, un administrateur de Lite Strategy, Inc. (ticker LITS), a fait état de l'achat de 10,000 actions ordinaires de la société le 09/30/2025. Le dépôt montre un prix d'achat moyen pondéré de $2.543 par action, avec des transactions individuelles évaluées entre $2.51 et $2.58. Après l'acquisition, Flynn détenait avantageusement 17,900 actions.

Le Formulaire 4 a été soumis le 10/02/2025 et signé par un mandataire. La personne déclarant se propose de fournir des détails sur la répartition du nombre d'actions par prix dans la fourchette divulguée sur demande.

Flynn James P, ein Direktor von Lite Strategy, Inc. (Tickersymbol LITS), berichtete über den Kauf von 10,000 Stammaktien des Unternehmens am 09/30/2025. Die Einreichung zeigt einen gewogenen Durchschnittspreis von $2.543 pro Aktie, wobei einzelne Transaktionen zwischen $2.51 und $2.58 lagen. Nach dem Erwerb besaß Flynn vorteilhaft 17,900 Aktien.

Das Formblatt 4 wurde am 10/02/2025 eingereicht und von einem Bevollmächtigten unterzeichnet. Die meldende Person bietet an, Details zur Aufteilung der Aktienanzahl nach Preis innerhalb des offengelegten Bereichs auf Anfrage bereitzustellen.

Flynn James P، مدير في Lite Strategy, Inc. (الرمز LITS)، أبلغ عن شراء 10,000 سهمًا من أسهم الشركة العادية في 09/30/2025. يظهر الملف أن سعر الشراء المتوسط المرجح بلغ $2.543 للسهم، مع صفقات فردية أسعارها بين $2.51 و $2.58. بعد الاستحواذ، أصبح Flynn يمتلك فعلياً 17,900 سهمًا.

تم تقديم النموذج 4 في 10/02/2025 وتوقيعه من قبل وكيل. يعرض الشخص المُبلغ أن يقدم تفاصيل حول تقسيم عدد الأسهم حسب السعر ضمن النطاق المُعلن عند الطلب.

Flynn James P,Lite Strategy, Inc. 的董事(股票代碼 LITS),在 09/30/2025 报告购买了公司普通股 10,000 股。申报显示每股加权平均购买价格为 $2.543,单笔交易价格在 $2.51$2.58 之间。收购后,Flynn 实益持有 17,900 股。

Form 4 于 10/02/2025 提交,并由代理人签名。申报人愿在要求时提供按价格在披露范围内的股票数量分布的细节。

Positive
  • Director purchase of 10,000 shares on 09/30/2025
  • Weighted-average price disclosed at $2.543 with range $2.51–$2.58
  • Post-transaction beneficial ownership reported as 17,900 shares
  • Form 4 filed and signed by attorney-in-fact on 10/02/2025
Negative
  • None.

Insights

Director purchased 10,000 shares, increasing ownership to 17,900.

The Form 4 documents a straightforward open-market acquisition by a director at a weighted-average price of $2.543, with a disclosed price range of $2.51–$2.58. Insider purchases can signal confidence in the company because a director is adding to their position.

This filing contains no additional transactions, derivative activity, or changes in control; it only reports the non‑derivative purchase and post-transaction beneficial ownership.

Form 4 filed promptly and includes weighted-average price disclosure.

The report meets Section 16 reporting by listing transaction date, price range, and post-transaction holdings, and is signed by an attorney-in-fact. The filer also offers to provide transaction-level detail on request, which supports transparency for regulators and shareholders.

Flynn James P, un direttore di Lite Strategy, Inc. (ticker LITS), ha riferito l'acquisto di 10,000 azioni ordinarie della società in data 09/30/2025. Il deposito mostra un prezzo medio ponderato di acquisto di $2.543 per azione, con transazioni individuali valutate tra $2.51 e $2.58. Dopo l'acquisizione, Flynn deteneva beneficiamente 17,900 azioni.

La presentazione del Form 4 è stata inviata il 10/02/2025 e firmata da un procuratore-in-fatto. La persona che segnala si offre di fornire dettagli sulla ripartizione del numero di azioni per prezzo all'interno dell'intervallo divulgato su richiesta.

Flynn James P, un director de Lite Strategy, Inc. (símbolo LITS), informó la compra de 10,000 acciones de las acciones ordinarias de la empresa el 09/30/2025. El informe muestra un precio de compra medio ponderado de $2.543 por acción, con transacciones individuales valuadas entre $2.51 y $2.58. Después de la adquisición, Flynn poseía beneficiosamente 17,900 acciones.

El Form 4 fue presentado el 10/02/2025 y firmado por un apoderado. La persona reportante ofrece proporcionar detalles sobre la distribución del conteo de acciones por precio dentro del rango divulgado a solicitud.

Flynn James P는 Lite Strategy, Inc.의 이사이며(주식 코드 LITS), 09/30/2025에 회사의 보통주 10,000주를 매수했다고 보고했다. 제출 서류에는 주당 가중평균 매수 가격이 $2.543이며, 개별 거래는 $2.51에서 $2.58 사이로 책정되었다. 인수 후 Flynn은 유익하게 17,900주를 소유하게 되었다.

Form 4는 10/02/2025에 제출되었고 대리인에 의해 서명되었다. 보고자는 공개된 범위 내의 가격별 주식 수 분할에 대한 세부 정보를 요청 시 제공하겠다고 제안한다.

Flynn James P, un administrateur de Lite Strategy, Inc. (ticker LITS), a fait état de l'achat de 10,000 actions ordinaires de la société le 09/30/2025. Le dépôt montre un prix d'achat moyen pondéré de $2.543 par action, avec des transactions individuelles évaluées entre $2.51 et $2.58. Après l'acquisition, Flynn détenait avantageusement 17,900 actions.

Le Formulaire 4 a été soumis le 10/02/2025 et signé par un mandataire. La personne déclarant se propose de fournir des détails sur la répartition du nombre d'actions par prix dans la fourchette divulguée sur demande.

Flynn James P, ein Direktor von Lite Strategy, Inc. (Tickersymbol LITS), berichtete über den Kauf von 10,000 Stammaktien des Unternehmens am 09/30/2025. Die Einreichung zeigt einen gewogenen Durchschnittspreis von $2.543 pro Aktie, wobei einzelne Transaktionen zwischen $2.51 und $2.58 lagen. Nach dem Erwerb besaß Flynn vorteilhaft 17,900 Aktien.

Das Formblatt 4 wurde am 10/02/2025 eingereicht und von einem Bevollmächtigten unterzeichnet. Die meldende Person bietet an, Details zur Aufteilung der Aktienanzahl nach Preis innerhalb des offengelegten Bereichs auf Anfrage bereitzustellen.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Flynn James P

(Last) (First) (Middle)
C/O LITE STRATEGY, INC.
9920 PACIFIC HEIGHTS BLVD., SUITE 150

(Street)
SAN DIEGO CA 92121

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Lite Strategy, Inc. [ LITS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/30/2025 A 10,000 A $2.543(1) 17,900 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The price reported is a weighted-average price. These shares were purchaased in multiple transactions with prices ranging from $2.51 to $2.58 per share. The reporting person undertakes to provide Lite Strategy, Inc., any security holders of Lite Strategy, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set in this Form 4.
/s/ Justin J. File, as attorney in fact 10/02/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Flynn James P report for Lite Strategy (LITS)?

The Form 4 reports a purchase of 10,000 shares of Lite Strategy common stock on 09/30/2025.

At what price were the LITS shares purchased?

The filing shows a weighted-average purchase price of $2.543 per share, with individual purchases ranging from $2.51 to $2.58.

How many LITS shares does the reporting person own after the transaction?

After the reported purchase, Flynn James P beneficially owned 17,900 shares.

When was the Form 4 for this LITS transaction filed?

The Form 4 was filed on 10/02/2025 and signed by an attorney-in-fact.

Does the filing include derivative transactions or option activity?

No. Table II for derivative securities is blank; only a non-derivative common stock purchase is reported.
Mei Pharma Inc

NASDAQ:LITS

LITS Rankings

LITS Latest News

LITS Latest SEC Filings

LITS Stock Data

87.36M
29.20M
Pharmaceutical Preparations
SAN DIEGO